Thanunrat Thongmee

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong et al. · Vaccines · 2022 · 89 citations · Full text

Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand

Sompong Vongpunsawad, Duangnapa Intharasongkroh, Thanunrat Thongmee et al. · PLoS ONE · 2017 · 86 citations · Full text

Vaccination, Vector-borne Pathogen, Southeast Asia +10

Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses

Nipaporn Tewawong, Slinporn Prachayangprecha, Preeyaporn Vichiwattana et al. · PLoS ONE · 2015 · 80 citations · Full text

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian et al. · Human Vaccines & Immunotherapeutics · 2022 · 66 citations · Full text

Immunology, Intermittent Supply Shortages, Vaccine Hesitancy +20

Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination

Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong et al. · The Journal of Infectious Diseases · 2022 · 61 citations